Dirk Brockstedt

Dirk Brockstedt

Chief Tech/Sci/R&D Officer presso RAPT THERAPEUTICS, INC.

Patrimonio netto: 249 824 $ in data 31/03/2024

55 anni
Health Technology
Consumer Services
Finance

Provenienza dei contatti di primo grado di Dirk Brockstedt

EntitàTipo di entitàSettore Industriale
Public Company Pharmaceuticals: Major 28
Extinct Pharmaceuticals: Major 19
18
Subsidiary Investment Managers 18
Public Company Medical Specialties 13
2
Extinct Medical Specialties 2

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Dirk Brockstedt tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
BAXTER INTERNATIONAL INC. Medical Specialties

Obi Greenman

Timothy Bruce Anderson

Corporate Officer/Principal

Corporate Officer/Principal

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

William R. Rohn

Michael Giordano

Linda Kozick

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Stephen Sherwin

David Goeddel

William Ho

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

PFIZER, INC. Pharmaceuticals: Major

Walter Moos

Ravi Kiron

David J. Wustrow

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Francis McCormick

Gregory W. Schafer

Walter Moos

Thomas Dubensky

Rekha Hemrajani

Liana Wu

Natalie Sacks

Founder

Director of Finance/CFO

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Jennifer Lew

Karen C. Lam

Comptroller/Controller/Auditor

Corporate Officer/Principal

University of California, Berkeley College/University

David N. Cook

Stephen T. Isaacs

John E. Hearst

Walter Moos

Stephen Munk

Thomas Dubensky

Justin Skoble

Doctorate Degree

Undergraduate Degree

Corporate Officer/Principal

Doctorate Degree

Doctorate Degree

Undergraduate Degree

Doctorate Degree

IMMUNE DESIGN CORP Pharmaceuticals: Major

Peter Svennilson

Sylvia R. Wheeler

Thomas Dubensky

Erin Campany

Director/Board Member

Investor Relations Contact

Chief Tech/Sci/R&D Officer

Human Resources Officer

Stanford University College/University

Obi Greenman

William Dawson

Wendye Robbins

Mohamad Tabrizi

Undergraduate Degree

Undergraduate Degree

Corporate Officer/Principal

Graduate Degree

Biotechnology

Walter Moos

Peter Svennilson

David Spellmeyer

Mohamad Tabrizi

Director/Board Member

Director/Board Member

Consultant / Advisor

Director/Board Member

College/University

Walter Moos

Lok Chung Chan

Paul Kassner

Undergraduate Degree

Doctorate Degree

Doctorate Degree

Miscellaneous Commercial Services

Xin Hui

Robert A. Drakas

Ya Jun Xu

Chairman

Corporate Officer/Principal

Founder

The Wharton School of the University of Pennsylvania College/University

Nipun Davar

Peter DiLaura

Liana Wu

Masters Business Admin

Undergraduate Degree

Undergraduate Degree

Investment Managers

David Goeddel

Peter Svennilson

Brian Wong

Private Equity Investor

Founder

Private Equity Investor

EXELIXIS, INC. Pharmaceuticals: Major

Francis McCormick

Rekha Hemrajani

Natalie Sacks

Director/Board Member

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

NGM BIOPHARMACEUTICALS, INC. Biotechnology

David Goeddel

William Rieflin

Peter Svennilson

Director/Board Member

Chairman

Director/Board Member

The University of California, San Francisco College/University

Stephen Sherwin

David Spellmeyer

Natalie Sacks

Corporate Officer/Principal

Doctorate Degree

Corporate Officer/Principal

RIGEL PHARMACEUTICALS, INC. Pharmaceuticals: Major

Stephen Sherwin

Walter Moos

Brian Wong

Director/Board Member

Director/Board Member

Corporate Officer/Principal

San Jose State University College/University

Gwen R. Carscadden

Erin Campany

Graduate Degree

Undergraduate Degree

University of Pennsylvania College/University

Gregory W. Schafer

Michael Listgarten

Undergraduate Degree

Undergraduate Degree

APELLIS PHARMACEUTICALS, INC. Pharmaceuticals: Major

Stephanie O'Brien

Lok Chung Chan

Director/Board Member

Chairman

Miscellaneous Commercial Services

Stephanie O'Brien

Lok Chung Chan

Director/Board Member

Director/Board Member

CHINOOK THERAPEUTICS, INC. Pharmaceuticals: Major

Obi Greenman

Walter Moos

Director/Board Member

Consultant / Advisor

Miscellaneous Commercial Services

Walter Moos

Krishna Kodukula

Corporate Officer/Principal

Corporate Officer/Principal

Information Technology Services

Peter DiLaura

Phyllis Loud Gray

Sales & Marketing

Human Resources Officer

The University of Chicago Booth School of Business College/University

Rodney Young

William Rieflin

Masters Business Admin

Masters Business Admin

Harvard T.H. Chan School of Public Health College/University

Natalie Sacks

Ya Jun Xu

Graduate Degree

Graduate Degree

Biotechnology

David N. Cook

Stephen T. Isaacs

Director/Board Member

Chairman

Harvard College College/University

David N. Cook

Stephanie O'Brien

Undergraduate Degree

Undergraduate Degree

The Johns Hopkins University College/University

Michael Giordano

Liana Wu

Undergraduate Degree

Graduate Degree

DYNAVAX TECHNOLOGIES CORPORATION Biotechnology

William Dawson

Jennifer Lew

Director of Finance/CFO

Director of Finance/CFO

Agricultural Commodities/Milling

Stephanie O'Brien

Lok Chung Chan

Director/Board Member

Founder

Pharmaceuticals: Major

Stephanie O'Brien

Lok Chung Chan

Director/Board Member

Director/Board Member

College/University

William Rieflin

Nina Mufti

Undergraduate Degree

Doctorate Degree

Kellogg School of Management College/University

James J. Vaughn

Rekha Hemrajani

Masters Business Admin

Masters Business Admin

Pharmaceuticals: Major

Rekha Hemrajani

Eric J. Hall

Director/Board Member

Director of Finance/CFO

University of California, Davis College/University

Eric J. Hall

Mohamad Tabrizi

Undergraduate Degree

Undergraduate Degree

FIVE PRIME THERAPEUTICS, INC. Biotechnology

Brian Wong

Lori Lyons-Williams

Corporate Officer/Principal

Director/Board Member

Miscellaneous Commercial Services

David Goeddel

Lok Chung Chan

Corporate Officer/Principal

Corporate Officer/Principal

XENOPORT, INC. Pharmaceuticals: Major

William Rieflin

David J. Wustrow

President

Corporate Officer/Principal

College/University

Robert Wild

Michele DeVries

Doctorate Degree

Undergraduate Degree

Brandeis University College/University

Robert Lutz

Ya Jun Xu

Doctorate Degree

Doctorate Degree

NURIX THERAPEUTICS, INC. Pharmaceuticals: Major

David Goeddel

Lisa Moore

Founder

Corporate Officer/Principal

Statistiche

Distribuzione geografica

Stati Uniti 48
Cina 2
Canada 2

Settori

Health Technology 25
Consumer Services 17
Commercial Services 7
Finance 2
Technology Services 2

Posizioni

Director/Board Member 249
Corporate Officer/Principal 152
Independent Dir/Board Member 76
Undergraduate Degree 62
Chairman 50